CancerSpeak: An American Cancer Society Journals Podcast22 Sep

Annual Report to the Nation: Cancer Trends and Progress Against Lung Cancer

What do the latest data tell us about cancer in the United States, and what’s behind the substantial progress against lung cancer over the past two decades?

In this episode of CancerSpeak, Jane Henley, MSPH, of the Centers for Disease Control and Prevention (CDC), is joined by Ahmedin Jemal, DVM, PhD, of the American Cancer Society (ACS); Serban Negoita, MD, DrPH, of the National Cancer Institute (NCI); and Recinda L. Sherman, MPH, PhD, ODS-C, of the North American Association of Central Cancer Registries (NAACCR) to discuss findings from the latest Annual Report to the Nation on the Status of Cancer. The group explores trends in cancer incidence and mortality, 21st century progress against lung cancer, changing breast and prostate cancer incidence, and findings among children, adolescents, and young adults.

Read “Annual Report to the Nation on the Status of Cancer, Featuring 21st Century Progress Against Lung Cancer,” now available in Cancer: https://bit.ly/ARNReport2026

Follow Cancer on social media:

x.com/JournalCancer instagram.com/acsjournals linkedin.com/company/acs-journals

Speakers in this conversation may have used shortened or informal terms rather than the precise terminology used in the published report. Please refer to the published article for exact definitions, categories, and classifications.

The findings and conclusions presented do not necessarily represent the official positions of the CDC; NCI, part of the National Institutes of Health; ACS; or NAACCR.

Original music by J. Gilman.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(26)

Advancing Pediatric and AYA Oncology: Perspectives from the Editors

Where is pediatric and adolescent and young adult (AYA) oncology headed—and what research is needed to move the field forward? In this episode of CancerSpeak, Dr. Nirali Shah, Editor-in-Chief of Pedia...

9 Sep 21min

Optimizing Asparaginase and Blinatumomab in Frontline Acute Lymphoblastic Leukemia

What are the latest recommendations for frontline acute lymphoblastic leukemia (ALL) treatment? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is j...

11 Aug 10min

Top Advances of the Year: Palliative and Supportive Care in Oncology

Palliative and supportive care helps reduce suffering, manage symptoms, and improve quality of life for people living with cancer, yet many patients still face barriers to accessing these services. Re...

13 Jul 21min

Post-MPN AML: Real-World Outcomes and Ongoing Challenges

Have newer therapies improved outcomes for patients with acute myeloid leukemia after myeloproliferative neoplasms, or post-MPN AML? In this episode of CancerSpeak, Cancer Hematologic Malignancies Sec...

23 Jun 13min

Antibody–Drug Conjugates: Clinical Perspectives from Europe

Dr. Daniel Morgensztern, Section Editor of Chest and Lung Disease for the journal Cancer, is joined by Dr. Emiliano Calvo and Dr. André Mansinho to discuss a new supplement in Cancer focused on recent...

2 Jun 22min

A New Home for Pediatric and AYA Oncology Research

In this episode of CancerSpeak, Dr. Nirali Shah is joined by Dr. William Dahut, Chief Scientific Officer of the American Cancer Society, and Dr. Suresh Ramalingam, Editor-in-Chief of Cancer, to discus...

19 Mai 13min

Low-Grade Gliomas: Evolving Approaches to Care

Dr. Priya Kumthekar, Neuro-Oncology Section Editor for CANCER, and Dr. Helen Shih, Radiation Oncology Section Editor for CANCER, discuss the current treatment landscape for low-grade gliomas with a fo...

7 Jan 15min